Accurate Clinical Research, Inc. is a privately held clinical research organization (CRO) headquartered in Richmond, Texas. Established in 2007 by Dr. Philip Waller and Karen Obmaces, the company specializes in conducting clinical trials across various therapeutic areas, including cardiology, oncology, rheumatology, primary care, and women's health. With over 30 years of combined experience in clinical trials, Accurate Clinical Research is dedicated to advancing medical knowledge and improving patient outcomes through rigorous research methodologies.
Key Strategic Focus
The company's strategic focus encompasses pre-clinical testing, Phase I-III trials, and post-approval studies. Accurate Clinical Research offers a comprehensive suite of services, including facility setup, study management, regulatory compliance, and training. Their expertise spans multiple therapeutic indications, with a particular emphasis on cardiology, dermatology, endocrinology, family medicine, and gastroenterology. By leveraging a network of compassionate physicians and experienced research coordinators, the company aims to discover solutions for tomorrow's medicines today, providing hope for patients and the future.
Financials and Funding
As of recent estimates, Accurate Clinical Research generates approximately $5 million in annual revenue and employs around 24 individuals. The company has raised a total of $150,000 in funding over one round. These financial resources are allocated towards expanding research capabilities, enhancing service offerings, and maintaining compliance with regulatory standards.
Pipeline Development
Accurate Clinical Research is actively involved in various stages of clinical trials, from early-phase studies to post-approval research. While specific pipeline candidates and target conditions are not publicly disclosed, the company's broad therapeutic expertise suggests ongoing projects in areas such as cardiology, oncology, and rheumatology. Timelines for anticipated milestones are project-dependent and align with industry standards for clinical development.
Technological Platform and Innovation
The company employs advanced technological platforms to streamline clinical trial processes and ensure data integrity. Proprietary technologies and significant scientific methods utilized by Accurate Clinical Research include:
- Electronic Data Capture (EDC) Systems: Facilitating efficient data collection and management.
- Clinical Trial Management Systems (CTMS): Enhancing study planning, tracking, and reporting.
- Standardized Assays: Ensuring consistency and reliability in laboratory analyses.
These tools enable the company to maintain high standards of quality and compliance throughout the clinical trial lifecycle.
Leadership Team
Accurate Clinical Research is led by a team of seasoned professionals:
- Dr. Philip Waller: Co-founder with extensive experience in clinical research and a commitment to advancing medical science.
- Karen Obmaces: Co-founder and Principal, overseeing operational aspects and strategic initiatives.
Their combined expertise ensures the company's adherence to rigorous research standards and ethical practices.
Competitor Profile
The clinical research industry is characterized by a competitive landscape with several key players:
- Firma Clinical Research: A CRO supporting drug development efforts with a focus on personalized service.
- Amarex Clinical Research: Specializes in conducting clinical trials with an emphasis on regulatory compliance.
- Symbio Research: Offers comprehensive clinical trial management services across various therapeutic areas.
- Cenexel CIT: Focuses on Phase I-IV trials, particularly in central nervous system and internal medicine.
These competitors provide similar services, necessitating Accurate Clinical Research to continually innovate and maintain high-quality standards to differentiate itself in the market.
Strategic Collaborations and Partnerships
While specific collaborations and partnerships are not publicly disclosed, Accurate Clinical Research likely engages with pharmaceutical companies, biotechnology firms, and academic institutions to conduct clinical trials. These alliances enhance the company's capabilities and contribute to the advancement of medical research.
Operational Insights
Accurate Clinical Research's strategic considerations include:
- Quality Assurance: Implementing robust quality control measures to ensure data integrity and compliance.
- Patient-Centric Approach: Prioritizing patient safety and engagement to enhance recruitment and retention.
- Regulatory Compliance: Staying abreast of evolving regulations to maintain adherence to industry standards.
These operational strategies position the company to effectively navigate the complexities of clinical research.
Strategic Opportunities and Future Directions
Looking ahead, Accurate Clinical Research aims to:
- Expand Therapeutic Areas: Diversify into additional medical fields to broaden research impact.
- Enhance Technological Capabilities: Invest in cutting-edge technologies to improve trial efficiency and data analysis.
- Strengthen Industry Partnerships: Forge new collaborations to access a wider range of clinical studies and resources.
By leveraging its current strengths and exploring these opportunities, Accurate Clinical Research is well-positioned to contribute significantly to the advancement of medical science.
Contact Information
For more detailed information or specific inquiries, please visit the company's official website.
